The State of ECG / EKG Collection During COVID-19

<h2><strong>Introduction [00:55]</strong></h2><p>Dr. David Albert of AliveCor explains how patient-collected data can solve some of the problems facing clinical trials during the COVID-19 pandemic, as well as the long-term outlook on changes in data collection for clinical research.</p><h2><strong>What is the AliveCor KardiaMobile 6L and how does it work? [01:43]</strong></h2><p>The <a href="https://www.ert.com/cardiac-safety/alivecor-kardiamobile-6l/">AliveCor KardiaMobile 6L</a> is a 6-lead device for patient-collected ECG/EKG reads.</p><h2><strong>How is the KardiaMobile 6L being used today in light of the COVID-19 pandemic and subsequent changes in FDA regulations? [03:21]</strong></h2><p>AliveCor received the FDA’s approval for emergency use of the KardiaMobile 6L. Some drugs being tested as treatments for COVID-19 may cause QT prolongation, potentially leading to a serious cardiac arrhythmia. The <a href="https://www.ert.com/cardiac-safety/alivecor-kardiamobile-6l/">KardiaMobile ...